SYK Patent: Neurodegenerative Disease Treatment Methods
Summary
USPTO published patent application US20260097056A1 disclosing SYK activators and inhibitors for treating neurodegenerative diseases. The application covers specific compounds and methods for disease treatment. Inventors: John R. Lukens, Hannah Elizabeth Ennerfelt, Elizabeth Frost. Filed September 20, 2023.
What changed
USPTO published patent application US20260097056A1 covering methods and compositions using SYK (Spleen Tyrosine Kinase) activators and inhibitors for treating neurodegenerative diseases. The application includes claims to various compound classes and treatment protocols.
Pharmaceutical companies and biotech firms researching neurodegeneration or SYK-targeting therapies may use this published application as prior art in freedom-to-operate analyses and research planning.
What to do next
- Monitor for updates
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SYK ACTIVATORS AND INHIBITORS IN NEURODEGENERATIVE DISEASES
Application US20260097056A1 Kind: A1 Apr 09, 2026
Inventors
John R. Lukens, Hannah Elzabeth Ennerfelt, Elizabeth Frost
Abstract
Provided herein are methods to treat neurodegenerative disease.
CPC Classifications
A61K 31/702 A61K 31/05 A61K 31/36 A61K 31/437 A61K 31/4985 A61K 31/501 A61K 31/506 A61K 31/519 A61K 31/5377 A61K 31/5383 A61K 31/675 A61P 25/28
Filing Date
2023-09-20
Application No.
19112913
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.